Company page

Personalis, Inc.

Personalis, Inc. (ticker: PSNL) is a public company based in the United States with a market capitalization of approximately $1.1 billion. The company specializes in advanced genomic sequencing and analysis, focusing on personalized medicine and cancer research. Personalis aims to improve patient outcomes through its innovative technologies and services in the healthcare sector.